位置:首页 > 蛋白库 > MDH_HALMA
MDH_HALMA
ID   MDH_HALMA               Reviewed;         304 AA.
AC   Q07841; Q5UZ29;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   03-AUG-2022, entry version 160.
DE   RecName: Full=Malate dehydrogenase {ECO:0000303|PubMed:8476859};
DE            EC=1.1.1.37 {ECO:0000269|PubMed:8476859};
GN   Name=mdh; OrderedLocusNames=rrnAC2706;
OS   Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM
OS   B-1809) (Halobacterium marismortui).
OC   Archaea; Euryarchaeota; Stenosarchaea group; Halobacteria; Halobacteriales;
OC   Haloarculaceae; Haloarcula.
OX   NCBI_TaxID=272569;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-55, FUNCTION,
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF ARG-83.
RX   PubMed=8476859; DOI=10.1021/bi00067a020;
RA   Cendrin F., Chroboczek J., Zaccai G., Eisenberg H., Mevarech M.;
RT   "Cloning, sequencing, and expression in Escherichia coli of the gene coding
RT   for malate dehydrogenase of the extremely halophilic archaebacterium
RT   Haloarcula marismortui.";
RL   Biochemistry 32:4308-4313(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809;
RX   PubMed=15520287; DOI=10.1101/gr.2700304;
RA   Baliga N.S., Bonneau R., Facciotti M.T., Pan M., Glusman G., Deutsch E.W.,
RA   Shannon P., Chiu Y., Weng R.S., Gan R.R., Hung P., Date S.V., Marcotte E.,
RA   Hood L., Ng W.V.;
RT   "Genome sequence of Haloarcula marismortui: a halophilic archaeon from the
RT   Dead Sea.";
RL   Genome Res. 14:2221-2234(2004).
RN   [3]
RP   SUBUNIT.
RX   PubMed=10653644; DOI=10.1021/bi9910023;
RA   Madern D., Ebel C., Mevarech M., Richard S.B., Pfister C., Zaccai G.;
RT   "Insights into the molecular relationships between malate and lactate
RT   dehydrogenases: structural and biochemical properties of monomeric and
RT   dimeric intermediates of a mutant of tetrameric L-[LDH-like] malate
RT   dehydrogenase from the halophilic archaeon Haloarcula marismortui.";
RL   Biochemistry 39:1001-1010(2000).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS).
RA   Dym O., Mevarech M., Sussman J.L.;
RT   "Structural features that stabilize halophilic malate-dehydrogenase from an
RT   archaebacterium.";
RL   Science 267:1344-1346(1995).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS), AND SUBUNIT.
RX   PubMed=10653643; DOI=10.1021/bi991001a;
RA   Richard S.B., Madern D., Garcin E., Zaccai G.;
RT   "Halophilic adaptation: novel solvent protein interactions observed in the
RT   2.9 and 2.6 A resolution structures of the wild type and a mutant of malate
RT   dehydrogenase from Haloarcula marismortui.";
RL   Biochemistry 39:992-1000(2000).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH NAD, AND SUBUNIT.
RX   PubMed=12581646; DOI=10.1016/s0022-2836(02)01450-x;
RA   Irimia A., Ebel C., Madern D., Richard S.B., Cosenza L.W., Zaccai G.,
RA   Vellieux F.M.D.;
RT   "The oligomeric states of Haloarcula marismortui malate dehydrogenase are
RT   modulated by solvent components as shown by crystallographic and
RT   biochemical studies.";
RL   J. Mol. Biol. 326:859-873(2003).
CC   -!- FUNCTION: Catalyzes the reversible oxidation of malate to oxaloacetate.
CC       {ECO:0000269|PubMed:8476859}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-malate + NAD(+) = H(+) + NADH + oxaloacetate;
CC         Xref=Rhea:RHEA:21432, ChEBI:CHEBI:15378, ChEBI:CHEBI:15589,
CC         ChEBI:CHEBI:16452, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.37;
CC         Evidence={ECO:0000269|PubMed:8476859};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.9 mM for oxaloacetate (in the presence of 2 M NaCl)
CC         {ECO:0000269|PubMed:8476859};
CC         KM=0.7 mM for oxaloacetate (in the presence of 4 M NaCl)
CC         {ECO:0000269|PubMed:8476859};
CC         Note=kcat is 197 sec(-1) with oxaloacetate as substrate (in the
CC         presence of 2 M NaCl). kcat is 69 sec(-1) with oxaloacetate as
CC         substrate (in the presence of 4 M NaCl).;
CC   -!- SUBUNIT: Homotetramer; arranged as a dimer of dimers.
CC       {ECO:0000269|PubMed:10653643, ECO:0000269|PubMed:10653644,
CC       ECO:0000269|PubMed:12581646}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8476859}.
CC   -!- MISCELLANEOUS: The quaternary structure is stabilized by chloride ions
CC       bound between the subunits. This may be an adaptation to the halophilic
CC       environment.
CC   -!- SIMILARITY: Belongs to the LDH/MDH superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M97218; AAA73368.1; -; Genomic_DNA.
DR   EMBL; AY596297; AAV47474.1; -; Genomic_DNA.
DR   PIR; A49496; A49496.
DR   RefSeq; WP_004959949.1; NZ_CP039138.1.
DR   PDB; 1D3A; X-ray; 2.94 A; A/B=2-304.
DR   PDB; 1HLP; X-ray; 3.20 A; A/B=2-304.
DR   PDB; 1O6Z; X-ray; 1.95 A; A/B/C/D=2-304.
DR   PDB; 2HLP; X-ray; 2.59 A; A/B=2-304.
DR   PDB; 2J5K; X-ray; 2.00 A; A/B/C/D=1-304.
DR   PDB; 2J5Q; X-ray; 2.15 A; A/B/C/D=1-304.
DR   PDB; 2J5R; X-ray; 2.25 A; A/B/C/D=1-304.
DR   PDB; 2X0R; X-ray; 2.92 A; A/B=1-304.
DR   PDB; 4JCO; X-ray; 1.70 A; A/B/C/D=1-304.
DR   PDB; 7Q3X; X-ray; 1.95 A; A/B/C/D=2-304.
DR   PDBsum; 1D3A; -.
DR   PDBsum; 1HLP; -.
DR   PDBsum; 1O6Z; -.
DR   PDBsum; 2HLP; -.
DR   PDBsum; 2J5K; -.
DR   PDBsum; 2J5Q; -.
DR   PDBsum; 2J5R; -.
DR   PDBsum; 2X0R; -.
DR   PDBsum; 4JCO; -.
DR   PDBsum; 7Q3X; -.
DR   AlphaFoldDB; Q07841; -.
DR   SMR; Q07841; -.
DR   STRING; 272569.rrnAC2706; -.
DR   EnsemblBacteria; AAV47474; AAV47474; rrnAC2706.
DR   GeneID; 40153569; -.
DR   GeneID; 64824029; -.
DR   KEGG; hma:rrnAC2706; -.
DR   PATRIC; fig|272569.17.peg.3289; -.
DR   eggNOG; arCOG00246; Archaea.
DR   HOGENOM; CLU_045401_1_1_2; -.
DR   OMA; CYIIVLT; -.
DR   BRENDA; 1.1.1.37; 2549.
DR   EvolutionaryTrace; Q07841; -.
DR   Proteomes; UP000001169; Chromosome I.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030060; F:L-malate dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019752; P:carboxylic acid metabolic process; IEA:InterPro.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW.
DR   CDD; cd01339; LDH-like_MDH; 1.
DR   Gene3D; 3.90.110.10; -; 1.
DR   InterPro; IPR001557; L-lactate/malate_DH.
DR   InterPro; IPR022383; Lactate/malate_DH_C.
DR   InterPro; IPR001236; Lactate/malate_DH_N.
DR   InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C.
DR   InterPro; IPR011275; Malate_DH_type3.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF02866; Ldh_1_C; 1.
DR   Pfam; PF00056; Ldh_1_N; 1.
DR   PIRSF; PIRSF000102; Lac_mal_DH; 1.
DR   PRINTS; PR00086; LLDHDRGNASE.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF56327; SSF56327; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Direct protein sequencing; NAD; Oxidoreductase;
KW   Reference proteome; Tricarboxylic acid cycle.
FT   CHAIN           1..304
FT                   /note="Malate dehydrogenase"
FT                   /id="PRO_0000113481"
FT   ACT_SITE        176
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P61889"
FT   BINDING         8..14
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12581646"
FT   BINDING         34
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12581646"
FT   BINDING         83
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P61889"
FT   BINDING         89
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P61889"
FT   BINDING         96
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12581646"
FT   BINDING         119..121
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:12581646"
FT   BINDING         121
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P61889"
FT   BINDING         152
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P61889"
FT   MUTAGEN         83
FT                   /note="R->Q: Substrate specificity changes from
FT                   oxaloacetate to pyruvate."
FT                   /evidence="ECO:0000269|PubMed:8476859"
FT   CONFLICT        19
FT                   /note="Y -> T (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..7
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   TURN            8..10
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           12..23
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          28..33
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           36..38
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           39..53
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   TURN            54..56
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           66..69
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          73..77
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           89..108
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          115..118
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           123..133
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:1O6Z"
FT   HELIX           138..140
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          141..143
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           146..161
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           165..167
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          172..174
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          180..182
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           198..216
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   TURN            217..219
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           224..238
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          244..253
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           254..256
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          258..269
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   STRAND          272..276
FT                   /evidence="ECO:0007829|PDB:4JCO"
FT   HELIX           283..303
FT                   /evidence="ECO:0007829|PDB:4JCO"
SQ   SEQUENCE   304 AA;  32808 MW;  0B5B630158CAD083 CRC64;
     MTKVSVVGAA GTVGAAAGYN IALRDIADEV VFVDIPDKED DTVGQAADTN HGIAYDSNTR
     VRQGGYEDTA GSDVVVITAG IPRQPGQTRI DLAGDNAPIM EDIQSSLDEH NDDYISLTTS
     NPVDLLNRHL YEAGDRSREQ VIGFGGRLDS ARFRYVLSEE FDAPVQNVEG TILGEHGDAQ
     VPVFSKVRVD GTDPEFSGDE KEQLLGDLQE SAMDVIERKG ATEWGPARGV AHMVEAILHD
     TGEVLPASVK LEGEFGHEDT AFGVPVRLGS NGVEEIVEWD LDDYEQDLMA DAAEKLSDQY
     DKIS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024